Medtronic   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Minneapolis MN United States (1949)

Organization Overview

First Clinical Trial
2001
NCT00587444
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

LifeGuard | Medtronic | Medtronic Atrial Fibrillation Solutions | Medtronic Bakken Research | Medtronic BRC | Medtronic Cardiac Rhythm and Heart Failure | Medtronic Corporate Technologies and New Ventures | Medtronic Diabetes | Medtronic Inc., Watford | Medtronic International Trading Sarl | Medtronic - MITG | MedtronicNeuro | Medtronic Neurovascular Clinical Affairs | Medtronic Pelvic Health | Medtronic Poland Spółka z ograniczoną odpowiedzialnością | Medtronic (Shanghai) Management Co. Ltd. | Medtronic Spinal and Biologics | Medtronic Vascular | Medtronic Ventures and New Therapies

Active Ingredients

Drugs in Phase 4 Trials (37)

Key: Medtronic (36) Acquired (1)

acetylsalicylic acid (aspirin) (8 trials)

adalimumab (humira) (1 trial)

amiodarone (cordarone) (1 trial)

apixaban (eliquis) (2 trials)

atenolol (tenormin) (1 trial)

baclofen (lioresal) (5 trials)

beractant (survanta) (1 trial)

carvedilol (coreg) (1 trial)

citalopram (celexa) (1 trial)

clopidogrel (plavix) (8 trials)

dabigatran (pradaxa) (1 trial)

desflurane (suprane) (1 trial)

escitalopram (lexapro) (1 trial)

exenatide (byetta) (1 trial)

flecainide (tambocor) (2 trials)

fluoxetine (prozac) (1 trial)

fluvoxamine (luvox) (1 trial)

hydrocodone (hycodan) (1 trial)

insulin aspart (Novolog) (1 trial)

insulin glargine (toujeo) (1 trial)

insulin human (humulin) (7 trials)

levobupivacaine (chirocaine) (1 trial)

metoprolol (lopressor) (3 trials)

morphine (1 trial)

paroxetine (paxil) (1 trial)

prasugrel (effient) (2 trials)

propafenone (rythmol) (2 trials)

propofol (diprivan) (2 trials)

rimabotulinumtoxinB (Myobloc) (1 trial)

rivaroxaban (xarelto) (1 trial)

sacubitril (Entresto) (1 trial)

sertraline (zoloft) (1 trial)

sotalol (betapace) (3 trials)

tenecteplase (tnkase) (1 trial)

thienoyridine (2 trials)

valsartan (diovan) (1 trial)

venlafaxine (effexor) (2 trials)

Drugs in Phase 3 Trials (20)

Key: Medtronic (14) Acquired (6)

alfuzosin (uroxatral) (1 trial)

alteplase (Activase) (4 trials)

atorvastatin (lipitor) (1 trial)

cephalexin (keflex) (1 trial)

clindamycin (cleocin) (1 trial)

diclofenac (voltaren) (2 trials)

eptifibatide (integrilin) (1 trial)

esomeprazole (nexium) (1 trial)

finasteride (Proscar) (1 trial)

heparin (liquaemin) (1 trial)

lansoprazole (prevacid) (1 trial)

levofloxacin (levaquin) (1 trial)

methacetin (1 trial)

mometasone (elocon) (3 trials)

omeprazole (prilosec) (1 trial)

polymyxin b sulfate (poly-rx) (1 trial)

rabeprazole (pariet) (1 trial)

sodium chloride (2 trials)

telmisartan (micardis) (1 trial)

verapamil (calan) (1 trial)

Drugs in Phase 2 Trials (13)

Key: Medtronic (11) Acquired (2)

bucindolol (1 trial)

clonidine (catapres) (1 trial)

epinephrine (levophed) (1 trial)

gabapentin (neurontin) (1 trial)

glatiramer acetate (copaxone) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

liatermin (1 trial)

mdt-10013 (2 trials)

mdt-15 (1 trial)

ocriplasmin (jetrea) (1 trial)

ribavirin (virazole) (1 trial)

snn0029 (2 trials)

snn0031 (1 trial)

Drugs in Phase 1 Trials (7)

Key: Medtronic (3) Acquired (4)

autologous bone graft (1 trial)

bone morphogenetic protein-2 (1 trial)

losartan (cozaar) (1 trial)

mk0736 (1 trial)

pioglitazone (actos) (1 trial)

simvastatin (zocor) (1 trial)

sitagliptin (januvia) (2 trials)

Drugs in Other Trials (22)

Key: Medtronic (20) Acquired (2)

bisacodyl (Halflytely) (1 trial)

bisoprolol (zebeta) (1 trial)

enoxaparin (lovenox) (2 trials)

erythromycin (ilosone) (1 trial)

glipizide (glucotrol) (1 trial)

ibutilide (corvert) (1 trial)

icosapent ethyl (vascepa) (1 trial)

lactulose (cephulac) (1 trial)

linagliptin (tradjenta) (1 trial)

magnesium oxide (1 trial)

methylene blue (proveblue) (1 trial)

metoclopramide (reglan) (1 trial)

nadroparin (1 trial)

olive (1 trial)

polyethylene glycol (1 trial)

potassium (1 trial)

ramipril (altace) (1 trial)

remifentanil (ultiva) (1 trial)

rifaximin (xifaxan) (1 trial)

rocuronium (zemuron) (2 trials)

sennosides a&b (1 trial)

sodium sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 2)

Atrial Fibrillation (Phase 4)

Atrial Flutter (Phase 2)

Back Pain (Phase 4)

Bone Diseases (Phase 1)

Brain Injuries (Phase 4)

Cerebral Palsy (Phase 3)

Chronic Pain (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Coronary Thrombosis (Phase 4)

Death (Phase 2)

Death, Sudden, Cardiac (Phase 2)

Delayed Emergence from Anesthesia (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Embolism (Phase 4)

Heart Arrest (Phase 2)

Heart Block (Phase 3)

Heart Failure (Phase 4)

Heart Failure, Systolic (Phase 3)

Hemorrhage (Phase 3)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hypercholesterolemia (Phase 3)

Hyperplasia (Phase 3)

Hypertension (Phase 2)

Hypoglycemia (Phase 4)

Infarction (Phase 4)

Infections (Phase 3)

Metabolic Syndrome (Phase 3)

Motor Neuron Disease (Phase 2)

Muscle Spasticity (Phase 4)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Obesity (Phase 4)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Pain, Intractable (Phase 2)

Pain, Postoperative (Phase 2)

Paralysis (Phase 3)

Parkinson Disease (Phase 2)

Postoperative Hemorrhage (Phase 3)

Postphlebitic Syndrome (Phase 3)

Postthrombotic Syndrome (Phase 3)

Prostatic Hyperplasia (Phase 3)

Radiculopathy (Phase 2)

Sciatica (Phase 2)

Sclerosis (Phase 2)

Sick Sinus Syndrome (Phase 3)

Syncope (Phase 3)

Syndrome (Phase 3)

Tachycardia (Phase 2)

Tachycardia, Ventricular (Phase 2)

Thromboembolism (Phase 4)

Thrombosis (Phase 4)

Venous Thromboembolism (Phase 3)

Venous Thrombosis (Phase 3)

Ventricular Fibrillation (Phase 2)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 87
  • # of Trial APIs: 99